Back to Search
DEEP SINGH
Behavior Technician
NPI: 1356029391Individual
Specialties, Licenses & Credentials
Behavior TechnicianPrimary
Behavior Technician
Code: 106S00000X
Clinical Trials (2)
2
Linked Trials
0
Recruiting
0
With Results
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
NCT05657860COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
NCT05615948COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (7)
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2).
PMID 32316080·J Clin Psychiatry·2020
3-trial
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
PMID 31734084·Am J Geriatr Psychiatry·2020
3-trial
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
PMID 31166571·JAMA Psychiatry·2019
3-trial
Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial.
PMID 25817884·Ann Emerg Med·2015
4-observational
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study.
PMID 16687994·Int Clin Psychopharmacol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6760 N WEST AVE STE 101
FRESNO, CA 93711 - Phone
- (833) 599-2560
Quick Facts
- NPI
- 1356029391
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 7
Are you this provider?
Claim Your Profile